Werkgroep Cardiologische centra Nederland

DAPA-HFrEF (Completed)

An International, Multicenter, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients with Chronic HFrEF
Medicine
dapagliflozin
Population
Heart failure
Phase
III
Starting year
2016

Publications: DAPA-HFrEF

  • Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering TherapyDiabetes Care - Abstract - DAPA-HFrEF - Heart failure
  • Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionNEJM - DAPA-HFrEF - Heart failure

Publications by WCN study

Publications WCN studies by WCN member